Monte Rosa Therapeutics, Inc. (13)

Browse by Contract Category

Contracts

Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated March 11, 2021 (Filed With SEC on June 4, 2021)
Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 4, 2021)
Form of Officer Indemnification Agreement (Filed With SEC on June 4, 2021)
License Agreement, dated as of April 10, 2018, among Cancer Research Technology Limited, The Institute of Cancer Research: Royal Cancer Hospital and Monte Rosa Therapeutics AG (Filed With SEC on June 4, 2021)
Lease Agreement, dated September 23, 2020, between OPG MP Parcel Owner (DE) LLC and the Registrant (Filed With SEC on June 4, 2021)
Form of Common Stock Certificate (Filed With SEC on June 4, 2021)
2020 Stock Option and Grant Plan, as amended, and forms of award agreements thereunder (Filed With SEC on June 4, 2021)
Form of Director Indemnification Agreement (Filed With SEC on June 4, 2021)
Contribution and Exchange Agreement, dated April 14, 2020, between certain shareholders of Monte Rosa Therapeutics AG and the Registrant (Filed With SEC on June 4, 2021)
Contribution and Exchange Agreement, dated September 1, 2020, between certain shareholders of Monte Rosa Therapeutics AG and the Registrant (Filed With SEC on June 4, 2021)
Services Agreement, dated as of April 10, 2018, between Ridgeline Therapeutics GmbH and Monte Rosa Therapeutics AG (Filed With SEC on June 4, 2021)
Services Agreement, dated as of December 29, 2020, between Monte Rosa Therapeutics AG and the Registrant (Filed With SEC on June 4, 2021)
Collaboration and Option Agreement, dated as of April 10, 2018, among Cancer Research Technology Limited, The Institute of Cancer Research: Royal Cancer Hospital and Monte Rosa... (Filed With SEC on June 4, 2021)